Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
Hayato Watanabe , Tsutomu Hayashi , Keisuke Koumori , Kazuki Kano , Yota Shimoda , Hirohito Fujikawa , Takanobu Yamada , Yasushi Rino , Munetaka Masuda , Takashi Ogata , Takashi Oshima
Background: Postoperative complications increased recurrence in gastric cancer (GC) patients. However, there was no study evaluating impact of postoperative complication among patients receiving adjuvant chemotherapy. The aim of present study was to investigate the impact of postoperative complications in pStage II/III GC patients who received adjuvant S-1 chemotherapy. Methods: The present study retrospectively examined GC patients who received curative gastrectomy followed by adjuvant S-1 chemotherapy between January 2000 and December 2011 at Kanagawa Cancer Center. The patients with postoperative complications were classified into PC group, and those without postoperative complications were into NC group. Clinicopathological characteristics and recurrence-free survival (RFS) were compared between the groups. Results: 226 patients were included in this study. Postoperative complication occurred in 30 patients (13.3%). Age (Median, range) is significantly higher in NC group (64, 24-86) than in PC group (59, 36-82) (p = 0.033). Total gastrectomy was predominant type of surgery in the PC group (73.3%) than in NC group (52.0%) (p = 0.031). There was no difference in gender, ASA score, tumor location, pathological stage (TNM 7th) and pathological type between two groups. Conclusions: Postoperative complications were an independent risk factor for RFS in pStage II/III GC patients who received curative gastrectomy followed by adjuvant S-1 chemotherapy.
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Toru Imai
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Chi Hoon Maeng
2023 ASCO Gastrointestinal Cancers Symposium
First Author: Souya Nunobe
2023 ASCO Gastrointestinal Cancers Symposium
First Author: Souya Nunobe